Pharmaceutical Lab Equipment Market to Hit USD 15.59 Billion by 2031, Driven by R&D and Biopharma Growth
BANGALORE, India, May 28, 2025 /PRNewswire/ -- Pharmaceutical Lab Equipment Market is Segmented by Type (Pretreatment Type, Reaction Type, Analysis & Test Type), by Application (Research Institutions, Pharmaceutical Factory).
The Global Market for Pharmaceutical Lab Equipment was valued at USD 11500 Million in the year 2024 and is projected to reach a revised size of USD 15590 Million by 2031, growing at a CAGR of 4.5% during the forecast period.
Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-32T9116/Global_Pharmaceutical_Lab_Equipment_Market
Major Factors Driving the Growth of Pharmaceutical Lab Equipment Market:
The pharmaceutical lab equipment market is undergoing robust growth due to heightened R&D activities, regulatory pressures, and advancements in drug development. From basic lab tools to advanced automation systems, the range of equipment needed has expanded significantly. Market players are investing in product innovations, partnerships, and geographic expansion to meet the evolving needs of pharmaceutical companies and research institutions.
The growing emphasis on precision medicine, biologics, and automation ensures a sustained demand trajectory. As labs continue to modernize and adopt digital technologies, the market is expected to witness continuous growth, fueled by scientific progress and global healthcare needs.
Unlock Insights: View Full Report Now!
https://reports.valuates.com/market-reports/QYRE-Auto-32T9116/global-pharmaceutical-lab-equipment
TRENDS INFLUENCING THE GROWTH OF THE PHARMACEUTICAL LAB EQUIPMENT MARKET:
The growth of the pharmaceutical lab equipment market is significantly driven by the demand for advanced analysis and test equipment. As pharmaceutical research becomes more specialized, laboratories require precise tools for analyzing complex chemical and biological compositions. Instruments such as chromatography systems, spectrometers, and particle size analyzers are in high demand for drug identification, purity testing, and formulation development. Regulatory authorities are also mandating stringent quality control processes, making sophisticated test equipment essential. Moreover, innovations in personalized medicine and biopharmaceuticals require lab devices that offer high-throughput screening and data accuracy. This surge in analytical demands is pushing companies to invest heavily in laboratory modernization, thereby accelerating market growth through the expansion of test-specific equipment portfolios.
Pretreatment types such as filtration, centrifugation, and sample digestion play a crucial role in driving the pharmaceutical lab equipment market. Pretreatment ensures that samples are accurately prepared before undergoing complex testing, which is vital for achieving reliable outcomes in clinical trials and pharmaceutical formulations. The increasing diversity of biological samples necessitates sophisticated pretreatment systems to ensure consistency and compliance with regulatory guidelines. Equipment such as automated homogenizers, centrifuges, and sample preparation robots are in growing demand to reduce human error and increase reproducibility. As pharmaceutical research evolves to include biologics and cell-based therapies, the necessity for advanced pretreatment methods has become indispensable, propelling investment in dedicated lab infrastructure and fueling market expansion.
Research institutions play a pivotal role in advancing the pharmaceutical lab equipment market by acting as major consumers of high-precision tools. These institutions are deeply involved in drug discovery, formulation development, and toxicology studies, requiring diverse equipment ranging from microplate readers to high-performance liquid chromatography (HPLC) systems. Government funding, academic grants, and public-private partnerships enable these institutions to invest in cutting-edge technology, which promotes innovation and demand for state-of-the-art lab tools. Additionally, collaborative projects between universities and pharma companies often include shared facilities equipped with the latest instrumentation, ensuring widespread adoption of lab technologies. The competitive need to publish high-impact research further drives institutions to maintain updated and advanced laboratories, directly contributing to the market's upward trajectory.
The escalating need for novel therapeutics is leading pharmaceutical companies to invest in robust drug discovery pipelines. This trend necessitates advanced lab equipment for screening, lead optimization, and compound analysis. Instruments like automated workstations, assay readers, and liquid handlers are indispensable in accelerating these processes. The demand for faster and more reliable screening technologies has fueled the procurement of specialized lab tools, enabling companies to identify potential drug candidates quickly and efficiently, thereby driving the overall market growth.
Pharmaceutical companies are under mounting pressure to comply with stringent quality and safety regulations. Agencies like the FDA and EMA require validated testing processes for every stage of drug development, which mandates the use of certified and accurate lab equipment. As a result, companies are upgrading their laboratories to include equipment that meets international standards, such as GLP and GMP compliance. This regulatory demand ensures sustained investment in quality lab infrastructure, boosting the pharmaceutical lab equipment market.
The shift towards biopharmaceuticals such as monoclonal antibodies, vaccines, and gene therapies has significantly impacted lab equipment needs. These complex biologics require precise conditions for production and testing, prompting demand for bioreactors, biosafety cabinets, and cell counters. The expansion of the biologics sector encourages labs to diversify their equipment portfolio to accommodate new testing methods, leading to considerable market expansion focused on advanced biological analysis.
The growing outsourcing of research to CROs is creating a parallel demand for pharmaceutical lab equipment. CROs are tasked with performing high-throughput analysis, requiring flexible and automated equipment to manage diverse projects. Since CROs often handle research for multiple clients, they invest in scalable, multifunctional lab systems. This dynamic drives sales in modular and cloud-integrated lab devices that can be adapted quickly to various testing protocols, thereby boosting overall market demand.
The need to increase throughput and reduce human error has resulted in widespread adoption of automated systems in pharmaceutical labs. Robotic sample handlers, integrated lab management systems, and AI-powered diagnostics are replacing manual procedures. These systems not only improve efficiency but also reduce long-term costs, encouraging labs to transition toward automation. This shift has increased the demand for programmable lab equipment, contributing significantly to the growth of the market.
Claim Yours Now! https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-32T9116&lic=single-user
PHARMACEUTICAL LAB EQUIPMENT MARKET SHARE:
GE Healthcare, Agilent Technologies, Waters, Danaher and Thermo Fisher Scientific are the leaders of the Pharmaceutical Lab Equipment Industry, which take about 50% market share.
North America is the major region of the global market, which takes about 35% market share. North America leads due to its concentration of pharmaceutical giants, robust academic research, and favorable government support for R&D.
Europe follows closely with its strong biotech sector and regulatory alignment across member states.
Asia-Pacific is emerging rapidly, driven by increasing investments in pharmaceutical manufacturing and clinical trials, especially in China and India.
Key Companies:
- GE Healthcare
- Waters
- Danaher
- Bruker
- Eppendorf
- Millipore
- Shimadzu
- Pace Analytical
- Perkin Elmer
- BRAND
- TELSTAR
- Agilent Technologies
- Thermo Fisher Scientific
Inquire for Discount: https://reports.valuates.com/request/discount/QYRE-Auto-32T9116/global-pharmaceutical-lab-equipment
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!
- Biopharmaceutical Lab Equipment Market
- PCR Lab Equipment Sets Market
- General Laboratory Equipment market is projected to grow from USD 23360 Million in 2023 to USD 33380 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
- The global Lab Consumables market was valued at USD 11320 Million in 2023 and is anticipated to reach USD 14040 Million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
- Laboratory Equipment Repair and Refurbishment Service Market
- Pharmaceutical Testing Equipment Market
- Supercritical Carbon Dioxide Extraction Equipment Market
DISCOVER OUR VISION: VISIT ABOUT US!
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
GET A FREE QUOTE
Valuates Reports
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
YouTube: https://www.youtube.com/@valuatesreports6753
https://www.facebook.com/valuateskorean
https://www.facebook.com/valuatesspanish
https://www.facebook.com/valuatesjapanese
https://valuatesreportspanish.blogspot.com/
https://valuateskorean.blogspot.com/
https://valuatesgerman.blogspot.com/
https://valuatesreportjapanese.blogspot.com/
Logo - https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharmaceutical-lab-equipment-market-to-hit-usd-15-59-billion-by-2031--driven-by-rd-and-biopharma-growth-302467435.html
SOURCE Valuates Reports